Showing 9701-9710 of 18563 results for "".
- Emerging Biomarkers and Genetic Insights Revolutionize Early Parkinson's Detectionhttps://reachmd.com/news/emerging-biomarkers-and-genetic-insights-revolutionize-early-parkinsons-detection/2475232/Overlooked until now, volatile compounds in ear wax and circulating T cell signatures are reshaping our approach to early Parkinson's disease detection, while genetic parallels from obsessive-compulsive disorder studies and prognostic insight
- Optimizing Knee Osteoarthritis Management in Physically Active Patients: Exploring Non-Pharmacological Interventionshttps://reachmd.com/news/optimizing-knee-osteoarthritis-management-in-physically-active-patients-exploring-non-pharmacological-interventions/2475235/Sports medicine specialists increasingly recognize that traditional medication regimens for knee osteoarthritis fall short for active patients, and emerging
- Reframing Infertility: An Early Predictor of Cardiovascular Riskhttps://reachmd.com/news/reframing-infertility-an-early-predictor-of-cardiovascular-risk/2475245/Emerging clinical evidence now positions infertility not only as a reproductive concern but also as a potential early indicator of cardiovascular risk in women, sparking urgent discussions among OB/GYN specialists and cardiologists about refr
- Evolving Role of NK Cells in Overcoming Tumor Resistance to Immune Checkpoint Blockadehttps://reachmd.com/news/evolving-role-of-nk-cells-in-overcoming-tumor-resistance-to-immune-checkpoint-blockade/2475241/Recent evidence is reshaping how we approach resistance to checkpoint inhibitors by revealing a paradoxical contribution of NK cells to tumor immune evasion. The persistent challenge for oncologists lies in overcoming resistance to imm
- Integrating California's Proposition 56 with Forensic Dental Research for Enhanced Smoking Cessation Strategieshttps://reachmd.com/news/integrating-californias-proposition-56-with-forensic-dental-research-for-enhanced-smoking-cessation-strategies/2475244/Integrating California’s landmark tobacco tax increase under Proposition 56 with innovative forensic dental research uncovers fresh strategies to drive smoking cessation and reshape public health policy. Tobacco tax increases have prov
- Integrating Pharmacist Guidance and Digital Technology in COPD Managementhttps://reachmd.com/news/integrating-pharmacist-guidance-and-digital-technology-in-copd-management/2475228/Despite multiple therapies, COPD patients frequently experience increased hospitalization rates and worsened symptom scores due to improper inhaler technique and unrecognized early exacerbations. Pulmonologists see firsthand how inhala
- Shifting Strategies in Treating Latent Tuberculosis: Targeting Dormancy via DosR Inhibitionhttps://reachmd.com/news/shifting-strategies-in-treating-latent-tuberculosis-targeting-dormancy-via-dosr-inhibition/2475202/As Mycobacterium tuberculosis cleverly evades treatment by entering a dormant state, innovative strategies targeting the Dormancy Survival Regulator (DosR) are emerging as pivotal in combatting latent tuberculosis (LTBI). Latent tuberc
- Evolving Pain Management: The Shift Toward Individualized Patient Carehttps://reachmd.com/news/evolving-pain-management-the-shift-toward-individualized-patient-care/2475194/Pain management is increasingly emphasizing personalized patient care, moving away from uniform protocols
- AI and Innovative Strategies in Cardiovascular Risk Assessmenthttps://reachmd.com/news/ai-and-innovative-strategies-in-cardiovascular-risk-assessment/2475208/Cardiovascular diseases are a leading cause of death globally. Innovative use of artificial intelligence (AI) in cardiovascular risk assessment is reshaping how risk is assessed and managed, providing new strategies for prevention. Des
- Navigating Adjuvant Chemotherapy in Elderly Patients with Stage II Colorectal Cancer: The Role of Frailtyhttps://reachmd.com/news/navigating-adjuvant-chemotherapy-in-elderly-patients-with-stage-ii-colorectal-cancer-the-role-of-frailty/2475199/Oncologists treating older patients with high-risk stage II colorectal cancer confront a delicate balance between the clear survival gains conferred by adjuvant chemotherapy for patients